Avanos Medical Posts Mixed Q1 2026 Results Amid Acquisition Deal
Event summary
- Avanos Medical reported Q1 2026 revenue of $182.2M, up 8.8% YoY, driven by 22.7% growth in its Specialty Nutrition Systems segment.
- Net income fell to $5.1M from $6.6M YoY, while adjusted net income declined to $10.6M from $12.0M.
- The company announced an all-cash acquisition by American Industrial Partners at an enterprise value of $1.272B.
- Free cash flow turned negative, with an outflow of $16.6M compared to an inflow of $19.0M in Q1 2025.
- Pain Management & Recovery segment sales were flat at $56.3M, with an operating loss of $1.8M.
The big picture
Avanos Medical's Q1 2026 results highlight a strategic inflection point, with strong growth in its nutrition segment contrasting with stagnation in pain management. The pending acquisition by American Industrial Partners for $1.272B suggests a shift in governance and potential operational realignment. The deal comes as the company faces cash flow challenges, raising questions about its ability to sustain momentum under new ownership.
What we're watching
- Segment Disparity
- Whether Avanos can address the underperformance in its Pain Management & Recovery segment amid the acquisition.
- Deal Execution
- The pace at which the acquisition by American Industrial Partners closes and integrates Avanos's operations.
- Cash Flow Recovery
- How Avanos plans to reverse its negative free cash flow trend ahead of the acquisition.
Related topics